We are live on
!
Find out more
AAM
Azzad Asset Management Portfolio holdings
AUM
$1.13B
1-Year Est. Return
38.47%
This Fund
S&P 500
This Quarter
Est. Return
+7.53%
1 Year Est. Return
+38.47%
3 Year Est. Return
+100.53%
5 Year Est. Return
+132.43%
10 Year Est. Return
+598.77%
AUM
$891M
AUM Growth
+$42.5M
(+5%)
Cap. Flow
-$6.15M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
21.42%
Holding
319
New
25
Increased
155
Reduced
125
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$4.83M |
| 2 |
Snowflake
SNOW
|
+$2.07M |
| 3 |
Corpay
CPAY
|
+$2.05M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$1.96M |
| 5 |
Cencora
COR
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$5.14M |
| 2 |
CrowdStrike
CRWD
|
+$4.76M |
| 3 |
Intuitive Surgical
ISRG
|
+$4.2M |
| 4 |
Magna International
MGA
|
+$2.75M |
| 5 |
Microchip Technology
MCHP
|
+$2.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.31% |
| 2 | Industrials | 14.28% |
| 3 | Healthcare | 13.79% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Consumer Staples | 8.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Recursion Pharmaceuticals
RXRX
$1.67B
| $98.8K | 0.01% |
14,997
-828
| -5% | -$5.94K |
|
302
CBAK Energy Technology Ltd
CBAT
$51.4M
| $45.4K | 0.01% |
36,312
-10,000
| -22% | -$11.2K |
|
|
KNDI
303
Kandi Technologies Group
KNDI
$68.6M
| $39.3K | ﹤0.01% |
19,085
| – | – |
|
304
Plug Power
PLUG
$2.85B
| $36.6K | ﹤0.01% |
+16,179
| New | +$36.3K |
|
|
SSKN
305
DELISTED
Strata Skin Sciences
SSKN
| $33K | ﹤0.01% |
+12,000
| New | +$37.5K |
|
306
Archer Aviation
ACHR
$3.97B
| $30.7K | ﹤0.01% |
+10,130
| New | +$38.7K |
|
|
BPT
307
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $10.8K | ﹤0.01% |
+10,000
| New | +$17.1K |
|
308
Albemarle
ALB
$15.2B
| – | – |
-23,471
| Closed | -$2.24M |
|
309
Cooper Companies
COO
$14.4B
| – | – |
-19,362
| Closed | -$1.69M |
|
|
310
CrowdStrike
CRWD
$209B
| – | – |
-49,668
| Closed | -$4.76M |
|
311
Enovis
ENOV
$1.51B
| – | – |
-15,579
| Closed | -$704K |
|
312
National Vision
EYE
$1.82B
| – | – |
-43,647
| Closed | -$571K |
|
313
Intuit
INTU
$88B
| – | – |
-332
| Closed | -$218K |
|
314
Lear
LEA
$8.1B
| – | – |
-11,968
| Closed | -$1.37M |
|
315
MediaAlpha
MAX
$741M
| – | – |
-43,173
| Closed | -$569K |
|
|
316
Magna International
MGA
$18.2B
| – | – |
-65,566
| Closed | -$2.75M |
|
317
Omnicell
OMCL
$1.66B
| – | – |
-13,100
| Closed | -$355K |
|
318
Valero Energy
VLO
$86.6B
| – | – |
-7,694
| Closed | -$1.21M |
|
319
WillScot Mobile Mini Holdings
WSC
$4.71B
| – | – |
-53,219
| Closed | -$2M |
|
Similar funds
PL
DFCM
AT
WM
OHIF
HMCP
EC
ACM
Azzad Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, Azzad Asset Management held 319 positions worth $891M, up 5% from $848M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Azzad Asset Management's Q3 2024 filing shows 25 new, 155 increased, 125 reduced and 12 closed positions. Its largest new stake was Mastercard: 10,386 shares worth $5.13M. The largest sale was Visa, an estimated $5.14M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Azzad Asset Management's largest Q3 2024 buy was Mastercard: 10,386 shares worth $5.13M.
- Azzad Asset Management added most to Novo Nordisk in Q3 2024, an estimated $1.96M increase.
- Azzad Asset Management's biggest Q3 2024 reduction was Visa, cutting an estimated $5.14M.
- Azzad Asset Management fully exited CrowdStrike in Q3 2024, selling an estimated $4.76M.
- Azzad Asset Management's ten largest holdings make up 21% of its $891M portfolio in Q3 2024.
- Azzad Asset Management opened 25 new positions and closed 12 in Q3 2024.
- Azzad Asset Management's portfolio value rose 5% quarter-over-quarter to $891M.
Based on Azzad Asset Management's 13F filing for Q3 2024, filed 7 Oct 2024.